Comment on: Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register

In this study it is shown that non-TNFi had a similar or even better response rate on both TNFi-na ïve and -resistant patients.
Source: Rheumatology - Category: Rheumatology Source Type: research